The Anti-Syndecan-1 (MM-specific glycoform) scFv-Fc antibody is a promising new research, diagnostic, and therapeutic tool specifically targeting a heavily sulfated glycoform of syndecan-1 (CD138) uniquely expressed on multiple myeloma (MM) cells. This high specificity minimizes off-target effects on normal blood cells and other tissues. The scFv-Fc format, comprising a single-chain variable fragment fused to the Fc region of human IgG1, confers both strong binding and the ability to induce antibody-dependent cellular cytotoxicity (ADCC).
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2506z | Mouse Anti-SDC1 Recombinant Antibody (clone 22B3) | WB, ELISA, FC, ICC | Mouse IgG1 |
NS-089CN | Mouse Anti-SDC1 Recombinant Antibody (NS-089CN) | ELISA | Mouse IgG |
HPAB-2546LY | Human Anti-SDC1 Recombinant Antibody (HPAB-2546LY) | ELISA | Humanized IgG4 |
ZG-0184U | Mouse Anti-Sdc1 Recombinant Antibody (clone 1B4F4) | ELISA | Mouse IgG1 |
ZG-0192U | Mouse Anti-SDC1 Recombinant Antibody (clone 3A2C8) | ELISA | Mouse IgG |
There are currently no Customer reviews or questions for VS-0325-FY153. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.